About Questcor Pharmaceuticals
Questcor Pharmaceuticals is a Healthcare company based in Anaheim (United States) founded in 1990, and was acquired by Mallinckrodt Pharmaceuticals in April 2014. Biopharmaceutical treatments for autoimmune and inflammatory disorders are developed. Questcor Pharmaceuticals has completed 1 acquisition, including BioVectra. Its focus areas include Diversified Pharmaceuticals.
Company details
Questcor Pharmaceuticals was founded in 1990 in Anaheim, United States, within the biopharmaceutical sector. Operations center on therapies for serious autoimmune and inflammatory conditions, with emphasis placed on neurology and nephrology fields. Research is supported for disorders exhibiting significant unmet medical needs. The main product, H.P. Acthar Gel, is approved by the FDA for 19 indications. Acquisition by Mallinckrodt was completed in 2014 for 5.8 billion USD.
- Headquarters Anaheim, United States
- Stage Acquired
- SectorsHealthcare
- Website questcor.com
- Social LinkedIn
- Acquired by Mallinckrodt Pharmaceuticals (Apr 2014)
- Investors
- Investments & Acquisitions
- Acquired byMallinckrodt Pharmaceuticals
(Apr 2014)
Investors in Questcor Pharmaceuticals
Questcor Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Mallinckrodt Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Specialty pharmaceutical products and diagnostic imaging agents are manufactured. | 1867 | mallinckrodt.com | St. Louis, United States |
Investor details for Questcor Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Questcor Pharmaceuticals
Questcor Pharmaceuticals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include BioVectra.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Microbial fermentation and CDMO services are specialized in by BioVectra. | biovectra.com | Charlottetown, Canada | 1970 | Jan 2013 | $100.5M |
Complete acquisition details for Questcor Pharmaceuticals
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Questcor Pharmaceuticals
3 dated milestones of Questcor Pharmaceuticals across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Questcor Pharmaceuticals is founded.
- Acquisition Acquires BioVectra.
- Exit Acquired by Mallinckrodt Pharmaceuticals.
Web traffic of Questcor Pharmaceuticals
Websites that share an audience with Questcor Pharmaceuticals (questcor.com).
Websites whose visitors overlap most with Questcor Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| jazzpharma.com | 21% | 86.1K | #530,349 | View details |
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as Questcor Pharmaceuticals (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 5.33 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Questcor Pharmaceuticals
Questcor Pharmaceuticals was founded in 1990.
Questcor Pharmaceuticals is headquartered in Anaheim, United States. It is registered at Anaheim, California, United States.
Questcor Pharmaceuticals was founded in 1990 in Anaheim, United States, within the biopharmaceutical sector. Operations center on therapies for serious autoimmune and inflammatory conditions, with emphasis placed on neurology and nephrology fields. Research is supported for disorders exhibiting significant unmet medical needs. The main product, H.P. Acthar Gel, is approved by the FDA for 19 indications. Acquisition by Mallinckrodt was completed in 2014 for 5.8 billion USD.
Questcor Pharmaceuticals has made 1 acquisition, including BioVectra.
Questcor Pharmaceuticals has 1 investor. Key investors include Mallinckrodt Pharmaceuticals.
Yes. Questcor Pharmaceuticals was acquired by Mallinckrodt Pharmaceuticals in April 2014.